Moist smokeless tobacco (Snus) use and risk of Parkinson’s disease
Author(s) -
Fei Yang,
Nancy L. Pedersen,
Weimin Ye,
Zhiwei Liu,
Margareta Norberg,
Lars Forsgren,
Ylva Trolle Lagerros,
Rino Bellocco,
Lars Alfredsson,
Anders Knutsson,
JanHåkan Jansson,
Patrik Wennberg,
Maria Rosaria Galanti,
Anton Lager,
Marzieh Araghi,
Michael Lundberg,
Cecilia Magnusson,
Karin Wirdefeldt
Publication year - 2016
Publication title -
international journal of epidemiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.406
H-Index - 208
eISSN - 1464-3685
pISSN - 0300-5771
DOI - 10.1093/ije/dyw294
Subject(s) - snus , medicine , smokeless tobacco , hazard ratio , confidence interval , relative risk , cohort study , proportional hazards model , lower risk , prospective cohort study , confounding , disease , parkinson's disease , cohort , environmental health , population , tobacco use
Cigarette smoking is associated with a lower risk of Parkinson's disease. It is unclear what constituent of tobacco smoke may lower the risk. Use of Swedish moist smokeless tobacco (snus) can serve as a model to disentangle what constituent of tobacco smoke may lower the risk. The aim of this study was to determine whether snus use was associated with a lower risk of Parkinson's disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom